Diabetes Mellitus and Thyroid Cancers: Risky Correlation, Underlying Mechanisms and Clinical Prevention

R Wu, J Zhang, G Zou, S Li, J Wang, X Li… - … Syndrome and Obesity, 2024 - Taylor & Francis
The incidences of thyroid cancer and diabetes are rapidly increasing worldwide. The
relationship between thyroid cancer and diabetes is a popular topic in medicine. Increasing …

Evolution of suppressing TSH therapy at diagnosis and in the long-term follow-up in a cohort of differentiated thyroid cancer

G Díaz-Soto, P Fernández-Velasco, BT Torres… - … , Diabetes y Nutrición …, 2022 - Elsevier
Introduction To evaluate the adequacy of TSH suppression therapy (TSHst) at the first
disease assessment and the last follow-up visit. Methods Retrospective observational study …

[HTML][HTML] Clinical inertia in thyrotropin suppressive therapy for low-risk differentiated thyroid cancer: A real-world experience at an endocrine center in Bangkok

Y Thewjitcharoen, W Chatchomchuan… - Medicine, 2024 - journals.lww.com
The management of low-risk differentiated thyroid cancer (DTC) has evolved over time
toward treatment de-escalation. However, overtreatment with supraphysiological dose of …

Thyroid-stimulating hormone suppressive therapy and osteoporosis: A review and meta-analysis

HO Mirghani, A Altowigri - Sudan Journal of Medical Sciences, 2022 - ajol.info
Background: Osteoporosis is a common morbid and mortal disease; thyroidstimulating
hormone (TSH) suppression is the state-of-the-art for postoperative differentiated thyroid …

RNA 甲基化在甲状腺癌中作用研究进展.

温思妮, 刘瀚元, 韩菲, 田润, 徐圣奉… - Journal of Modern …, 2023 - search.ebscohost.com
及促甲状腺激素(TSH) 刺激等有关[5], 且发病群体呈年轻化[6]. 因此, 有必要阐明THCA
发生和进展的分子机制. 事实上, 深入了解THCA 病变的潜在分子机制可能有助于发现更好的 …

智能化辅助调药系统在甲状腺乳头状癌患者术后内分泌抑制治疗中的应用

陈承坤, 陶玄斌, 张颖超, 邓先兆, 郭伯敏, 丁政, 李鸣… - 中国普通外科杂志, 2022 - zpwz.net
摘要背景与目的: 甲状腺癌发病率快速上升, 甲状腺乳头状癌(PTC) 术后长期内分泌抑制治疗是
降低复发的重要手段, 然而, 患者多次往返门诊明显增加了医疗负荷和医疗费用 …

[PDF][PDF] 超声弹性成像联合血清TSH, TK1, LMTK3 对甲状腺乳头状癌的诊断价值及与肿瘤侵袭和增殖的关系研究

吴达熙, 黄禾菁, 周群群, 陶乐… - Progress in Modern …, 2023 - biomed.cnjournals.com
摘要目的: 探讨超声弹性成像(UE) 联合血清促甲状腺激素(TSH), 胸苷激酶1 (TK1), Lemur-
酪氨酸激酶3 (LMTK3) 对甲状腺乳头状癌(PTC) 的诊断价值及与肿瘤侵袭和增殖的关系. 方法 …

[PDF][PDF] Metabolické a endokrinní choroby–je náš přístup vždy racionální?

L Brunerová, J Urbanová, J Brož - Vnitřní lékařství, 2021 - casopisvnitrnilekarstvi.cz
Choosing wisely in metabolic and endocrine diseases shows the inutility of some, in clinical
practice often used, ways of management. In diabetology, the routine recommendation for …

[HTML][HTML] Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis

B Xu, SY Gu, NM Zhou, JJ Jiang - Open Life Sciences, 2023 - degruyter.com
High thyroid stimulating hormone (TSH) levels may stimulate papillary thyroid cancer (PTC)
cell proliferation; however, the relationship between TSH levels and PTC risk remains …

[HTML][HTML] Are There Long-Term Adverse Effects of T3 Therapy for Hypothyroidism? We All Want to Know!

N Genere, T Cubb - Clinical Thyroidology, 2022 - liebertpub.com
Background Levothyroxine (L-T4) therapy is the standard of care for individuals with
hypothyroidism; it effectively controls biochemical and clinical features of hypothyroidism in …